Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-21-031663

Options or other derivatives

  • Director acquired 4,167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bray June Director 2021-03-01 Grant or award · Stock Option (Right to Buy) +4,167 4,167 D
Loading xslF345X03/tm217124-6_4seq1.xml…